2
RESEARCH METHODOLOGY
36
5
MARKET OVERVIEW
Exosome research surges with rising R&D investment, despite technical and regulatory challenges.
56
5.2.1.1
INCREASING INVESTMENT IN PHARMACEUTICAL AND LIFE SCIENCES R&D
5.2.1.2
RISING FOCUS ON DEVELOPMENT OF CANCER THERAPEUTICS AND DIAGNOSTICS
5.2.1.3
GROWING INTEREST IN EXOSOME-BASED PROCEDURES
5.2.2.1
TECHNICAL COMPLEXITY OF EXOSOME ISOLATION AND CHARACTERIZATION
5.2.2.2
REGULATORY COMPLICATIONS AND UNCERTAINTY IN EXOSOME RESEARCH
5.2.3.1
HIGH INVESTMENTS IN EMERGING ECONOMIES
5.2.3.2
GROWING INTEREST IN EXOSOME-BASED THERAPEUTICS
5.2.3.3
RISING DEMAND FOR PERSONALIZED MEDICINES
5.2.4.1
LACK OF STANDARD PROTOCOLS FOR EXOSOME MANUFACTURING AND DEVELOPMENT
5.2.4.2
LIMITED UNDERSTANDING OF CARGO LOADING CAPACITY
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4.1
INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY KEY PLAYER, 2024
5.4.2
INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY REGION, 2024
5.6
SUPPLY CHAIN ANALYSIS
5.8.1.1
ULTRACENTRIFUGATION
5.8.1.2
NANOPARTICLE TRACKING ANALYSIS (NTA)
5.8.2
COMPLIMENTARY TECHNOLOGIES
5.8.2.2
WESTERN BLOTTING/ELISA
5.8.3
ADJACENT TECHNOLOGIES
5.8.3.1
NEXT-GENERATION SEQUENCING
5.8.3.2
MASS SPECTROMETRY
5.9.1
NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
5.9.2
LIST OF KEY PATENTS, 2023–2024
5.10
KEY CONFERENCES & EVENTS, 2025–2026
5.11.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2
REGULATORY FRAMEWORK
5.11.2.4
REST OF THE WORLD
5.12
PORTER’S FIVE FORCES ANALYSIS
5.12.1
THREAT OF NEW ENTRANTS
5.12.2
THREAT OF SUBSTITUTES
5.12.3
BARGAINING POWER OF SUPPLIERS
5.12.4
BARGAINING POWER OF BUYERS
5.12.5
INTENSITY OF COMPETITIVE RIVALRY
5.13
KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2
KEY BUYING CRITERIA
5.14
INVESTMENT & FUNDING SCENARIO
5.15.1
IMPORT DATA FOR HS CODE 3822, 2020–2024
5.15.2
EXPORT DATA FOR HS CODE 3822, 2020–2024
5.16
IMPACT OF AI/GEN AI ON EXOSOME RESEARCH MARKET
5.17
IMPACT OF 2025 US TARIFF ON EXOSOME RESEARCH MARKET
5.17.3
PRICE IMPACT ANALYSIS
5.17.4
IMPACTS ON COUNTRY/REGION
5.17.5
IMPACT ON END-USE INDUSTRIES
5.17.5.1
ACADEMIC & RESEARCH INSTITUTES
5.17.5.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.17.5.3
HOSPITALS & CLINICAL LABORATORIES
6
EXOSOME RESEARCH MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 38 Data Tables
101
6.2.1.1
HIGH DEMAND FOR EXOSOME-BASED MARKERS FOR DISEASE DETECTION TO PROPEL MARKET GROWTH
6.2.2
ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS
6.2.2.1
AVAILABILITY OF RAPID AND EASY-TO-USE KITS & REAGENTS TO ENSURE SUSTAINED DEMAND
6.2.3
OTHER KITS & REAGENTS
6.3.1
DEMAND FOR SCALABLE EXOSOME DEVELOPMENT THROUGH HIGH-THROUGHPUT SYSTEMS TO DRIVE GROWTH
6.4.1
LACK OF IN-HOUSE RESOURCES TO SUPPORT MARKET GROWTH
7
EXOSOME RESEARCH MARKET, BY INDICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 62 Data Tables
119
7.2.1.1
INCREASING DEMAND FOR ADVANCED DIAGNOSTICS FOR LUNG CANCER TO PROPEL MARKET GROWTH
7.2.2.1
INCREASED AWARENESS AND FOCUS ON BETTER NON-INVASIVE DIAGNOSIS TO AID MARKET GROWTH
7.2.3.1
EFFECTIVENESS OF LIQUID BIOPSY IN DETECTING PROSTATE CANCER BEFORE SURGERY TO SUPPORT MARKET GROWTH
7.2.4.1
RISING FOCUS ON EXOSOME-BASED RESEARCH ON TUMOR INITIATION, PROGRESSION, CHEMORESISTANCE, AND METASTASIS TO DRIVE MARKET
7.3
NEURODEGENERATIVE DISEASES
7.3.1
INCREASED APPLICATION OF SALIVARY EXOSOMAL CARGO CONTENT IN DISEASE TREATMENT TO PROPEL MARKET GROWTH
7.4
CARDIOVASCULAR DISEASES
7.4.1
GREATER RESEARCH FOCUS ON EXTRACELLULAR VESICLES TO AUGMENT MARKET GROWTH
7.5.1
POTENTIAL FOR EXOSOMES IN DEVELOPING NOVEL INFECTIOUS DISEASE TREATMENTS TO AID ADOPTION
8
EXOSOME RESEARCH MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 25 Data Tables
147
8.2.1
ABILITY TO MODULATE CELL SIGNALING AND REDUCE NEUROINFLAMMATION TO DRIVE ADOPTION
8.3.1
NEED FOR COMBATING INFECTIOUS DISEASES TO SPUR ADOPTION OF EXOSOME-BASED VACCINES
8.4.1
MINIMAL SIDE EFFECTS AND HIGH EFFICACY OF EXOSOMES IN TISSUE REGENERATION TO SUPPORT ADOPTION
9
EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 1 Data Tables
160
9.2
STEM CELL-DERIVED EXOSOME MANUFACTURING
9.2.1
INCREASE IN DEMAND FOR MESENCHYMAL STEM CELLS-BASED EXOSOMES IN THERAPEUTICS TO AUGMENT MARKET GROWTH
9.3
DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING
9.3.1
SIGNIFICANT DEVELOPMENTS IN DENDRITIC CELL-BASED EXOSOME IMMUNOTHERAPY TO DRIVE MARKET
9.4
OTHER MANUFACTURING SERVICES
10
EXOSOME RESEARCH MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 19 Data Tables
163
10.2
ACADEMIC & RESEARCH INSTITUTES
10.2.1
INCREASING NUMBER OF CANCER AND STEM CELL RESEARCH PROJECTS GLOBALLY TO AUGMENT MARKET GROWTH
10.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1
HIGH INVESTMENTS AND RAPID INNOVATIONS IN EXOSOME-BASED DIAGNOSTICS TO AID MARKET GROWTH
10.4
HOSPITALS & CLINICAL TESTING LABORATORIES
10.4.1
RISING ADOPTION OF EXOSOME-BASED ONCOLOGY RESEARCH SOLUTIONS TO PROPEL MARKET GROWTH
11
EXOSOME RESEARCH MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 156 Data Tables.
173
11.2.1
MACROECONOMIC ANALYSIS FOR NORTH AMERICA
11.2.2.1
US TO DOMINATE NORTH AMERICAN EXOSOME RESEARCH MARKET DURING STUDY PERIOD
11.2.3.1
INCREASING FUNDING FOR GENOME-BASED MEDICAL TREATMENTS TO SUPPORT MARKET GROWTH
11.3.1
MACROECONOMIC ANALYSIS FOR EUROPE
11.3.2.1
ADVANCED BIOTECHNOLOGY SECTOR AND DEVELOPED RESEARCH FACILITIES TO FAVOR MARKET GROWTH
11.3.3.1
FAVORABLE R&D INITIATIVES AND ADVANCED LIFE SCIENCE INDUSTRY TO DRIVE MARKET
11.3.4.1
INCREASING COLLABORATIONS BETWEEN BIOTECHNOLOGY FIRMS AND RESEARCH INSTITUTES TO PROPEL MARKET GROWTH
11.3.5.1
FAVORABLE GOVERNMENT POLICIES TO PROPEL GROWTH OF EXOSOME RESEARCH
11.3.6.1
INCREASED FOCUS ON PHARMACEUTICAL R&D TO AID MARKET GROWTH
11.4.1
MACROECONOMIC ANALYSIS FOR ASIA PACIFIC
11.4.2.1
FAVORABLE GOVERNMENT INITIATIVES FOR DEVELOPMENT OF BIOTECHNOLOGY INDUSTRY TO DRIVE MARKET
11.4.3.1
HIGH PREVALENCE OF CANCER AND INCREASED HEALTHCARE EXPENDITURE TO AID MARKET GROWTH
11.4.4.1
INCREASING NUMBER OF INSTITUTIONAL ALLIANCES AND GROWING FOCUS ON CLINICAL INNOVATION TO SUPPORT MARKET GROWTH
11.4.5.1
SUBSTANTIAL GOVERNMENT FUNDING AND INNOVATIVE APPLICATIONS IN REGENERATIVE MEDICINES TO AUGMENT MARKET GROWTH
11.4.6.1
FAVORABLE GOVERNMENT INITIATIVES AND ROUTINE CLINICAL TRIALS TO SUPPORT MARKET GROWTH
11.4.7
REST OF ASIA PACIFIC
11.5.1
MACROECONOMIC ANALYSIS FOR LATIN AMERICA
11.5.2.1
INCREASED GOVERNMENT INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET
11.5.3.1
ADVANCEMENTS IN REGENERATIVE MEDICINES AND EXOSOME-BASED THERAPIES TO SUPPORT MARKET GROWTH
11.5.4
REST OF LATIN AMERICA
11.6
MIDDLE EAST & AFRICA
11.6.1
MACROECONOMIC ANALYSIS FOR MIDDLE EAST & AFRICA
11.6.2.1
STRONG FOCUS ON LOCAL PHARMACEUTICAL R&D TO FUEL MARKET GROWTH
11.6.3
REST OF MIDDLE EAST & AFRICA
12
COMPETITIVE LANDSCAPE
Discover key strategies and market leaders shaping the exosome research competitive landscape.
250
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EXOSOME RESEARCH MARKET
12.3
REVENUE ANALYSIS, 2020–2024
12.4
MARKET SHARE ANALYSIS, 2024
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.5.5.1
COMPANY FOOTPRINT
12.5.5.2
REGION FOOTPRINT
12.5.5.3
OFFERING FOOTPRINT
12.5.5.4
INDICATION FOOTPRINT
12.5.5.5
APPLICATION FOOTPRINT
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.6.1
PROGRESSIVE COMPANIES
12.6.2
RESPONSIVE COMPANIES
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
12.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY OFFERING AND REGION
12.7
COMPANY VALUATION & FINANCIAL METRICS
12.8
BRAND/PRODUCT COMPARISON
12.9
COMPETITIVE SCENARIO
12.9.1
PRODUCT LAUNCHES & APPROVALS
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
270
13.1.1
THERMO FISHER SCIENTIFIC INC.
13.1.1.1
BUSINESS OVERVIEW
13.1.1.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
13.1.1.3
RECENT DEVELOPMENTS
13.1.6
SYSTEM BIOSCIENCES, LLC
13.1.10
NORGEN BIOTEK CORP.
13.1.11
AETHLON MEDICAL, INC.
13.1.12
CREATIVE MEDICAL TECHNOLOGIES HOLDINGS, INC.
13.1.15
IZON SCIENCE LIMITED
13.1.16
CAPRICOR THERAPEUTICS, INC.
13.2.1
ANJARIUM BIOSCIENCES AG
13.2.4
ILIAS BIOLOGICS INC.
13.2.7
CELL GUIDANCE SYSTEM LLC
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3
CUSTOMIZATION OPTIONS
TABLE 1
EXOSOME RESEARCH MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 3
EXOSOME RESEARCH MARKET: RISK ANALYSIS
TABLE 4
EXOSOME RESEARCH MARKET: IMPACT ANALYSIS
TABLE 5
GLOBAL CANCER INCIDENCE, BY REGION, 2022 VS. 2025
TABLE 6
INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY KEY PLAYER, 2024
TABLE 7
INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY REGION, 2024 (USD)
TABLE 8
EXOSOME RESEARCH MARKET: ROLE IN ECOSYSTEM
TABLE 9
EXOSOME RESEARCH MARKET: NUMBER OF PATENTS FILED, 2014–2024
TABLE 10
EXOSOME RESEARCH MARKET: DETAILED ANALYSIS OF KEY PATENTS, 2023–2024
TABLE 11
EXOSOME RESEARCH MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 12
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
EXOSOME RESEARCH MARKET: PORTER’S FIVE FORCES
TABLE 17
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
TABLE 18
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 19
IMPORT DATA FOR HS CODE 3822, 2020–2024 (USD THOUSAND)
TABLE 20
EXPORT DATA FOR HS CODE 3822, 2020–2024 (USD THOUSAND)
TABLE 21
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 22
EXOSOME RESEARCH PRODUCTS-RELATED TARIFF REVISION
TABLE 23
EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 24
EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 25
NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 26
EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 27
ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 28
LATIN AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 29
MIDDLE EAST & AFRICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 30
EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 31
ANTIBODIES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 32
NORTH AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33
EUROPE: ANTIBODIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 34
ASIA PACIFIC: ANTIBODIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35
LATIN AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36
MIDDLE EAST & AFRICA: ANTIBODIES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 37
ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 38
NORTH AMERICA: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39
EUROPE: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 40
ASIA PACIFIC: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
LATIN AMERICA: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42
MIDDLE EAST & AFRICA: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
OTHER KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
NORTH AMERICA: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
EUROPE: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46
ASIA PACIFIC: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47
LATIN AMERICA: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
MIDDLE EAST & AFRICA: OTHER KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 49
EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 50
NORTH AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51
EUROPE: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52
ASIA PACIFIC: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
LATIN AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
MIDDLE EAST & AFRICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 55
EXOSOME RESEARCH SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
NORTH AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57
EUROPE: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58
ASIA PACIFIC: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59
LATIN AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
MIDDLE EAST & AFRICA: EXOSOME RESEARCH SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 61
EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 62
EXOSOME RESEARCH MARKET FOR CANCER, BY REGION, 2023–2030 (USD MILLION)
TABLE 63
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 64
EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR CANCER, BY REGION, 2023–2030 (USD MILLION)
TABLE 68
EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 69
LUNG CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 70
NORTH AMERICA: LUNG CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71
EUROPE: LUNG CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
ASIA PACIFIC: LUNG CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
LATIN AMERICA: LUNG CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 74
MIDDLE EAST & AFRICA: LUNG CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 75
BREAST CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 76
NORTH AMERICA: BREAST CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77
EUROPE: BREAST CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78
ASIA PACIFIC: BREAST CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79
LATIN AMERICA: BREAST CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 80
MIDDLE EAST & AFRICA: BREAST CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 81
PROSTATE CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 82
NORTH AMERICA: PROSTATE CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83
EUROPE: PROSTATE CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84
ASIA PACIFIC: PROSTATE CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85
LATIN AMERICA: PROSTATE CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86
MIDDLE EAST & AFRICA: PROSTATE CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 87
COLORECTAL CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 88
NORTH AMERICA: COLORECTAL CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89
EUROPE: COLORECTAL CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
ASIA PACIFIC: COLORECTAL CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91
LATIN AMERICA: COLORECTAL CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92
MIDDLE EAST & AFRICA: COLORECTAL CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 93
OTHER CANCERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 94
NORTH AMERICA: OTHER CANCERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95
EUROPE: OTHER CANCERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 96
ASIA PACIFIC: OTHER CANCERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97
LATIN AMERICA: OTHER CANCERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98
MIDDLE EAST & AFRICA: OTHER CANCERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 99
EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 100
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 101
EUROPE: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 105
EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 106
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2030(USD MILLION)
TABLE 107
EUROPE: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2030(USD MILLION)
TABLE 108
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2030(USD MILLION)
TABLE 109
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2030(USD MILLION))
TABLE 110
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023–2030(USD MILLION)
TABLE 111
EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 112
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113
EUROPE: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 115
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 116
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 117
EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 118
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119
EUROPE: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 120
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 122
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 123
EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 124
EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 125
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 126
EUROPE: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 128
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129
MIDDLE EAST & AFRICA & AFRICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 130
EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 131
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 132
EUROPE: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 133
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 134
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 136
EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 137
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138
EUROPE: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 139
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 141
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 142
EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 143
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144
EUROPE: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 145
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 146
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 148
EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE, 2023–2030 (USD MILLION)
TABLE 149
EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 150
EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 151
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152
EUROPE: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 153
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 155
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 156
EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 157
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 158
EUROPE: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 159
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 160
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 161
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 162
EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 163
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 164
EUROPE: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 165
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 166
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 167
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 168
EXOSOME RESEARCH MARKET: KEYWORD RELEVANCE, TREND, AND PRIMARY FOCUS, 2015–2024
TABLE 169
EXOSOME RESEARCH MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 170
NORTH AMERICA: KEY MACROINDICATORS
TABLE 171
NORTH AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172
NORTH AMERICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 173
NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174
NORTH AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 175
NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
NORTH AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 177
NORTH AMERICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 178
US: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 179
US: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
US: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 181
US: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
US: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 183
US: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 184
CANADA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 185
CANADA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186
CANADA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 187
CANADA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
CANADA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 189
CANADA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 190
EUROPE: KEY MACROINDICATORS
TABLE 191
EUROPE: EXOSOME RESEARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 192
EUROPE: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 193
EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 195
EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196
EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 197
EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 198
GERMANY: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 199
GERMANY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200
GERMANY: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 201
GERMANY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202
GERMANY: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 203
GERMANY: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 204
UK: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 205
UK: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
UK: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 207
UK: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208
UK: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 209
UK: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 210
FRANCE: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 211
FRANCE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
FRANCE: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 213
FRANCE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214
FRANCE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 215
FRANCE: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 216
ITALY: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 217
ITALY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
ITALY: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 219
ITALY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 220
ITALY: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 221
ITALY: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 222
SPAIN: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 223
SPAIN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224
SPAIN: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 225
SPAIN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 226
SPAIN: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 227
SPAIN: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 228
REST OF EUROPE: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 229
REST OF EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230
REST OF EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 231
REST OF EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
REST OF EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 233
REST OF EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 234
ASIA PACIFIC: KEY MACROINDICATORS
TABLE 235
ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 236
ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 237
ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 238
ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 239
ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 241
ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 242
CHINA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 243
CHINA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 244
CHINA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 245
CHINA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 246
CHINA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 247
CHINA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 248
JAPAN: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 249
JAPAN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
JAPAN: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 251
JAPAN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 252
JAPAN: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 253
JAPAN: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 254
INDIA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 255
INDIA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256
INDIA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 257
INDIA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 258
INDIA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 259
INDIA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 260
AUSTRALIA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 261
AUSTRALIA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 262
AUSTRALIA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 263
AUSTRALIA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 264
AUSTRALIA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 265
AUSTRALIA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 266
SOUTH KOREA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 267
SOUTH KOREA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 268
SOUTH KOREA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 269
SOUTH KOREA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 270
SOUTH KOREA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 271
SOUTH KOREA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 272
REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 273
REST OF ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 274
REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 275
REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 276
REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 277
REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 278
LATIN AMERICA: KEY MACROINDICATORS
TABLE 279
LATIN AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 280
LATIN AMERICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 281
LATIN AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 282
LATIN AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 283
LATIN AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284
LATIN AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 285
LATIN AMERICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 286
BRAZIL: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 287
BRAZIL: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288
BRAZIL: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 289
BRAZIL: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 290
BRAZIL: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 291
BRAZIL: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 292
MEXICO: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 293
MEXICO: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294
MEXICO: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 295
MEXICO: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 296
MEXICO: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 297
MEXICO: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 298
REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 299
REST OF LATIN AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300
REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 301
REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302
REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 303
REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 304
MIDDLE EAST & AFRICA: KEY MACROINDICATORS
TABLE 305
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 306
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 307
MIDDLE EAST & AFRICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 308
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 309
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 310
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 311
MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 312
GCC COUNTRIES: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 313
GCC COUNTRIES: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 314
GCC COUNTRIES: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 315
GCC COUNTRIES: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 316
GCC COUNTRIES: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 317
GCC COUNTRIES: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 318
REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 319
REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 320
REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 321
REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 322
REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 323
REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 324
OVERVIEW OF MAJOR STRATEGIES DEPLOYED BY KEY PLAYERS IN EXOSOME RESEARCH MARKET, JANUARY 2022–MAY 2025
TABLE 325
EXOSOME RESEARCH MARKET: DEGREE OF COMPETITION
TABLE 326
EXOSOME RESEARCH MARKET: REGION FOOTPRINT
TABLE 327
EXOSOME RESEARCH MARKET: OFFERING FOOTPRINT
TABLE 328
EXOSOME RESEARCH MARKET: INDICATION FOOTPRINT
TABLE 329
EXOSOME RESEARCH MARKET: APPLICATION FOOTPRINT
TABLE 330
EXOSOME RESEARCH MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 331
EXOSOME RESEARCH MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SME PLAYERS, BY OFFERING AND REGION, 2024
TABLE 332
EXOSOME RESEARCH MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025
TABLE 333
EXOSOME RESEARCH MARKET: DEALS, JANUARY 2022–MAY 2025
TABLE 334
EXOSOME RESEARCH MARKET: EXPANSIONS, JANUARY 2022–MAY 2025
TABLE 335
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 336
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 337
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–MAY 2025
TABLE 338
QIAGEN: COMPANY OVERVIEW
TABLE 339
QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 340
QIAGEN: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 341
LONZA: COMPANY OVERVIEW
TABLE 342
LONZA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 343
LONZA: DEALS, JANUARY 2022–MAY 2025
TABLE 344
LONZA: EXPANSIONS, JANUARY 2022–MAY 2025
TABLE 345
DANAHER: COMPANY OVERVIEW
TABLE 346
DANAHER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 347
DANAHER: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 348
DANAHER: DEALS, JANUARY 2022–MAY 2025
TABLE 349
BIO-TECHNE: COMPANY OVERVIEW
TABLE 350
BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 351
BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 352
SYSTEM BIOSCIENCES, LLC: COMPANY OVERVIEW
TABLE 353
SYSTEM BIOSCIENCES, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 354
AMSBIO: COMPANY OVERVIEW
TABLE 355
AMSBIO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 356
ROOSTERBIO, INC.: COMPANY OVERVIEW
TABLE 357
ROOSTERBIO, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 358
ROOSTERBIO, INC.: DEALS, JANUARY 2022–MAY 2025
TABLE 359
MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 360
MILTENYI BIOTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 361
MILTENYI BIOTEC: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 362
NORGEN BIOTEK CORP.: COMPANY OVERVIEW
TABLE 363
NORGEN BIOTEK CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 364
AETHLON MEDICAL, INC.: COMPANY OVERVIEW
TABLE 365
AETHLON MEDICAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 366
AETHLON MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025
TABLE 367
CREATIVE MEDICAL TECHNOLOGIES HOLDINGS, INC.: COMPANY OVERVIEW
TABLE 368
CREATIVE MEDICAL TECHNOLOGIES HOLDINGS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 369
SPECTRIS: COMPANY OVERVIEW
TABLE 370
SPECTRIS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 371
SPECTRIS: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 372
SPECTRIS: DEALS, JANUARY 2022–MAY 2025
TABLE 373
NANOFCM, INC.: COMPANY OVERVIEW
TABLE 374
NANOFCM, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 375
IZON SCIENCE LIMITED: COMPANY OVERVIEW
TABLE 376
IZON SCIENCE LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 377
CAPRICOR THERAPEUTICS, INC.: COMPANY OVERVIEW
TABLE 378
CAPRICOR THERAPEUTICS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 379
ANJARIUM BIOSCIENCES AG: COMPANY OVERVIEW
TABLE 380
CILOA: COMPANY OVERVIEW
TABLE 381
INNOVAPREP: COMPANY OVERVIEW
TABLE 382
ILIAS BIOLOGICS INC.: COMPANY OVERVIEW
TABLE 383
UNCHAINED LABS: COMPANY OVERVIEW
TABLE 384
RION INC.: COMPANY OVERVIEW
TABLE 385
CELL GUIDANCE SYSTEM LLC: COMPANY OVERVIEW
TABLE 386
INOVIQ: COMPANY OVERVIEW
TABLE 387
NX PHARMAGEN: COMPANY OVERVIEW
TABLE 388
EXOPHARM: COMPANY OVERVIEW
TABLE 389
EVERZOM: COMPANY OVERVIEW
TABLE 390
NANOSOMIX: COMPANY OVERVIEW
TABLE 391
CREATIVE BIOLABS: COMPANY OVERVIEW
FIGURE 1
EXOSOME RESEARCH MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
EXOSOME RESEARCH MARKET: YEARS CONSIDERED
FIGURE 3
EXOSOME RESEARCH MARKET: RESEARCH DESIGN
FIGURE 4
EXOSOME RESEARCH MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5
EXOSOME RESEARCH MARKET: BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS)
FIGURE 6
EXOSOME RESEARCH MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
FIGURE 7
COMPANY REVENUE ANALYSIS-BASED ESTIMATION: BOTTOM-UP APPROACH (2024)
FIGURE 8
REVENUE SHARE ANALYSIS OF THERMO FISHER SCIENTIFIC INC. (2024)
FIGURE 9
EXOSOME RESEARCH MARKET: KEY INSIGHTS FROM PRIMARIES
FIGURE 10
EXOSOME RESEARCH MARKET: TOP-DOWN APPROACH
FIGURE 11
EXOSOME RESEARCH MARKET: CAGR PROJECTIONS
FIGURE 12
EXOSOME RESEARCH MARKET: DATA TRIANGULATION
FIGURE 13
EXOSOME RESEARCH MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
FIGURE 14
EXOSOME RESEARCH MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 15
EXOSOME RESEARCH MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 16
EXOSOME RESEARCH MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 17
REGIONAL SNAPSHOT OF EXOSOME RESEARCH MARKET
FIGURE 18
HIGH DEMAND FOR PRECISION MEDICINES AND STRONG PHARMACEUTICAL R&D INFRASTRUCTURE TO DRIVE MARKET
FIGURE 19
US AND BIOMARKERS COMMANDED LARGEST SHARE OF NORTH AMERICAN EXOSOME RESEARCH MARKET IN 2024
FIGURE 20
US TO WITNESS HIGHEST CAGR FROM 2025 TO 2030
FIGURE 21
EXOSOME RESEARCH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22
EXOSOME RESEARCH MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 23
INDICATIVE PRICE OF EXOSOME KITS & REAGENTS, BY KEY PLAYER (2024)
FIGURE 24
INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY REGION (2024)
FIGURE 25
EXOSOME RESEARCH MARKET: VALUE CHAIN ANALYSIS
FIGURE 26
EXOSOME RESEARCH MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 27
EXOSOME RESEARCH MARKET: ECOSYSTEM ANALYSIS
FIGURE 28
EXOSOME RESEARCH MARKET: TOP PATENT APPLICANTS/OWNERS AND NUMBER OF PATENTS GRANTED, JANUARY 2014–DECEMBER 2024
FIGURE 29
EXOSOME RESEARCH MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 30
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 31
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 32
EXOSOME RESEARCH MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024
FIGURE 33
EXOSOME RESEARCH MARKET: IMPACT OF AI/GEN AI
FIGURE 34
NORTH AMERICA: EXOSOME RESEARCH MARKET SNAPSHOT
FIGURE 35
EUROPE: EXOSOME RESEARCH MARKET SNAPSHOT
FIGURE 36
REVENUE ANALYSIS OF KEY PLAYERS IN EXOSOME RESEARCH MARKET, 2020–2024 (USD MILLION)
FIGURE 37
MARKET SHARE ANALYSIS OF KEY PLAYERS IN EXOSOME RESEARCH MARKET (2024)
FIGURE 38
EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 39
EXOSOME RESEARCH MARKET: COMPANY FOOTPRINT
FIGURE 40
EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 41
EV/EBITDA OF KEY VENDORS
FIGURE 42
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 43
EXOSOME RESEARCH MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 44
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 45
QIAGEN: COMPANY SNAPSHOT
FIGURE 46
LONZA: COMPANY SNAPSHOT
FIGURE 47
DANAHER: COMPANY SNAPSHOT
FIGURE 48
BIO-TECHNE: COMPANY SNAPSHOT
FIGURE 49
AETHLON MEDICAL, INC.: COMPANY SNAPSHOT
FIGURE 50
CREATIVE MEDICAL TECHNOLOGIES HOLDINGS, INC.: COMPANY SNAPSHOT
FIGURE 51
SPECTRIS: COMPANY SNAPSHOT
FIGURE 52
CAPRICOR THERAPEUTICS, INC.: COMPANY SNAPSHOT
Growth opportunities and latent adjacency in Exosome Research Market